New psychoactive substances: a review and updates

A Shafi, AJ Berry, H Sumnall… - Therapeutic …, 2020 - journals.sagepub.com
New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

New psychoactive substances: challenges for drug surveillance, control, and public health responses

A Peacock, R Bruno, N Gisev, L Degenhardt, W Hall… - The Lancet, 2019 - thelancet.com
The rapid emergence since the mid-2000s of a large and diverse range of substances
originally designed as legal alternatives to more established illicit drugs (pragmatically …

Structure of a signaling cannabinoid receptor 1-G protein complex

KK Kumar, M Shalev-Benami, MJ Robertson, H Hu… - Cell, 2019 - cell.com
Cannabis elicits its mood-enhancing and analgesic effects through the cannabinoid receptor
1 (CB1), a G protein-coupled receptor (GPCR) that signals primarily through the adenylyl …

Cannabis, cannabinoids, and health

G Lafaye, L Karila, L Blecha… - Dialogues in clinical …, 2017 - Taylor & Francis
Cannabis (also known as marijuana) is the most frequently used illicit psychoactive
substance in the world. Though it was long considered to be a “soft” drug, studies have …

Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives

E Gracia-Lor, S Castiglioni, R Bade, F Been… - Environment …, 2017 - Elsevier
The information obtained from the chemical analysis of specific human excretion products
(biomarkers) in urban wastewater can be used to estimate the exposure or consumption of …

The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

VL Alves, JL Gonçalves, J Aguiar… - Critical Reviews in …, 2020 - Taylor & Francis
The word “cannabinoid” refers to every chemical substance, regardless of structure or origin,
that joins the cannabinoid receptors of the body and brain and that have similar effects to …

Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal

ZD Cooper - Current psychiatry reports, 2016 - Springer
Although several chemical structural classes of synthetic cannabinoids (SCs) were recently
classified as Schedule I substances, rates of use and cases of serious toxic effects remain …

Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective

K Cohen, AM Weinstein - Frontiers in public health, 2018 - frontiersin.org
There is a growing use of novel psychoactive substances containing synthetic cannabinoids.
Synthetic cannabinoid products have effects similar to those of natural cannabis, yet, these …

Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health

AM Weinstein, P Rosca, L Fattore… - Frontiers in psychiatry, 2017 - frontiersin.org
As part of an increasing worldwide use of designer drugs, recent use of compounds
containing cathinones and synthetic cannabinoids is especially prevalent. Here, we …

Synthetic cannabinoids

B Mills, A Yepes, K Nugent - The American journal of the medical sciences, 2015 - Elsevier
Synthetic cannabinoids (SCBs), also known under the brand names of “Spice,”“K2,”“herbal
incense,”“Cloud 9,”“Mojo” and many others, are becoming a large public health concern due …